Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of APL 400-003, a Candidate HIV Vaccine, in HIV-Negative Volunteers

NCT00001538 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.

NCT NCT00001538
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00001538 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of APL 400-003, a Candidate HIV Vaccine, in HIV-Negative Volunteers
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Phase
Phase 1
Overall status
Completed
Start date
March 31, 1996
Completion date
April 30, 2001
Enrollment
41
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acquired immunodeficiency syndrome, hiv infection